Management of warfarin (coumarin) overdose (Q47855451)

6 February 2018

review article

1 reference

title

Management of warfarin (coumarin) overdose (English)

1 reference

6 February 2018

1 reference

1 reference

Baglin T

1

1 reference

6 February 2018

publication date

1 June 1998

1 reference

6 February 2018

published in

Blood Reviews

1 reference

6 February 2018

volume

12

1 reference

6 February 2018

issue

2

1 reference

6 February 2018

page(s)

91-98

1 reference

6 February 2018

Guidelines on oral anticoagulation: third edition

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990020-0

7 January 2021

Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990020-0

7 January 2021

Optimal oral anticoagulant therapy in patients with mechanical heart valves.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990020-0

7 January 2021

Bleeding complications in oral anticoagulant therapy. An analysis of risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990020-0

7 January 2021

Clinical Pharmacokinetics of Oral Anticoagulants

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990020-0

7 January 2021

Mechanism of coumarin action: significance of vitamin K epoxide reductase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990020-0

7 January 2021

Protein binding of warfarin enantiomers in serum of humans and rats

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990020-0

7 January 2021

Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990020-0

7 January 2021

Warfarin metabolism in man: identification of metabolites in urine

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990020-0

7 January 2021

Pharmacokinetics and dialysability of warfarin in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990020-0

7 January 2021

Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990020-0

7 January 2021

Pharmacokinetics and pharmacodynamics of warfarin at steady state

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990020-0

7 January 2021

Temporary discontinuation of warfarin therapy: changes in the international normalized ratio

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990020-0

7 January 2021

Comparison of prothrombin complex concentrate and vitamin K1 in oral anticoagulant reversal

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990020-0

7 January 2021

Guidelines for the use of fresh frozen plasma. British Committee for Standards in Haematology, Working Party of the Blood Transfusion Task Force

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990020-0

7 January 2021

Reduced coagulation activation following infusion of a highly purified factor IX concentrate compared to a prothrombin complex concentrate

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990020-0

7 January 2021

New-variant Creutzfeldt-Jakob disease and treatment of haemophilia. Executive Committee of the UKHCDO. United Kingdom Haemophilia Centre Directors' Organisation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990020-0

7 January 2021

EVIDENCE FOR "REBOUND" HYPERCOAGULABILITY AFTER STOPPING ANTICOAGULANTS

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990020-0

7 January 2021

Plasma hypercoagulability after termination of oral anticoagulants

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990020-0

7 January 2021

Protein C response to induction and withdrawal of oral anticoagulant treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990020-0

7 January 2021

Hypercoagulable state and thromboembolism following warfarin withdrawal in post-myocardial-infarction patients

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990020-0

7 January 2021

Evolution of blood coagulation and fibrinolysis parameters after abrupt versus gradual withdrawal of acenocoumarol in patients with venous thromboembolism: a double-blind randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990020-0

7 January 2021

Computer assisted management of warfarin treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990020-0

7 January 2021

10.1016/S0268-960X(98)90020-0

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018